The Medtech Flywheel
Every candidate in the knowledge base, what is actually known about it, and what it would take to finish its packet. Generated from the candidate files — nothing here is hand-written.
Why the verified share is low, and why that is on the
page. Only three of the nine rubric factors have any verification path at all —
Regulatory, Reimbursement and FTO/IP. TAM has no free authoritative source, and factors
5–9 are judgments no database can answer. On top of that the CMS cache files are absent
and EPO_OPS_KEY/EPO_OPS_SECRET are unset, so most reimbursement and patent checks
return "nothing was searched" rather than a finding. Read a low count as a statement
about the tooling, not about the idea.
Home Stress-Incontinence Stimulator
Vet Wound Negative-Pressure Therapy
Home Newborn Phototherapy Device
Pediatric Home Sleep Apnea Test
Tinnitus Neuromodulation Device
Office Hemorrhoid RF Treatment
Adjustable Lymphedema Compression Wrap
Fingerstick Potassium/Creatinine Meter
Wearable Hyperkalemia ECG Patch
Pediatric Home Spirometry Monitor
Why the board shows a posture and does not sort by it.
A posture is read off one candidate's own decision queue: repair-pending means
something it cannot survive has been refuted and the loop owes an answer,
evidence-gated means the biggest open question is knowable, and
ready-to-read means a human should look — never that the idea is good.
Those readings are not comparable between candidates. A critical pillar
on a veterinary device and a critical pillar on a Class III implant are not the
same amount of anything, so ordering this list by posture or exposure would produce a
portfolio ranking assembled out of things that do not rank. Read a row; do not read the
column. unassessed is a state, not a low score — it means nobody has yet written
down what that idea rests on.
None of this is a recommendation. Shortlist review, legal and clinical sign-off and capital allocation are human-only. This board compiles what the candidate files say; it ranks nothing and advises nothing.